Vincerx Pharma, Inc. (VINC) SEC Filings — 2025
17 SEC filings for Vincerx Pharma, Inc. (VINC) in 2025.
Filings
- Vincerx Pharma Files Additional Proxy Materials — DEFA14A · Jul 16, 2025
- Vincerx Pharma Announces Executive Changes and Agreement Termination — 8-K · Jul 7, 2025
- Vincerx Pharma Files Proxy Materials — DEFA14A · Jun 18, 2025
- Vincerx Pharma Files Additional Proxy Materials — DEFA14A · Jun 6, 2025
- Vincerx Pharma Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Vincerx Pharma Files Proxy Statement for June Meeting — DEF 14A · May 12, 2025
- Vincerx Pharma Faces Delisting Concerns — 8-K · Apr 17, 2025
- Vincerx Pharma Terminates Material Definitive Agreement — 8-K · Apr 11, 2025
- Vincerx Pharma Files 2024 10-K After Reverse Stock Split — 10-K · Mar 27, 2025
- Vincerx Pharma Enters Material Definitive Agreement — 8-K · Mar 18, 2025
- Vincerx Pharma Terminates Material Definitive Agreement — 8-K · Feb 28, 2025
- Vincerx Pharma to be Acquired by LifeSci Acquisition Corp. — 8-K · Feb 18, 2025
- Vincerx Pharma Files 8-K, Reports Material Agreement — 8-K · Feb 6, 2025
- Vincerx Pharma Proxy Filing — DEFA14A · Jan 29, 2025
- Vincerx Pharma Files 8-K — 8-K · Jan 23, 2025
- Vincerx Pharma Files 8-K: Material Agreement, Other Events — 8-K · Jan 21, 2025
- Vincerx Pharma Terminates Material Agreement — 8-K · Jan 16, 2025